이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

라세르투스 증후군에 대한 키네시오 테이핑

2026년 11월 10일 업데이트: Husam Taha, Arab American University (Palestine)

라세르투스 증후군 환자의 통증 감소와 손 기능 및 악력 향상에 대한 키네시오 테이핑을 추가한 보존적 치료의 효과: 파일럿 무작위 대조 시험

Background: Lacertus syndrome is a condition in which the median nerve is compressed at the lacertus fibrosus in the proximal forearm, leading to pain, numbness, weakness, and reduced hand function. The current standard treatment is surgical release. However, surgery may not be accessible or preferred by all patients, particularly in healthcare settings with limited resources. There is very little research on non-surgical treatment options for this condition.

Purpose: The purpose of this pilot study is to evaluate the feasibility and preliminary effectiveness of adding Kinesio Taping to a standardized conservative treatment program for adults diagnosed with lacertus syndrome.

Design: This is a single-blind, parallel-group, pilot randomized controlled trial with a 1:1 allocation ratio. Thirty adults aged 18 to 65 years with a confirmed diagnosis of lacertus syndrome will be randomly assigned to one of two groups: (1) an experimental group receiving therapeutic Kinesio Taping applied over the lacertus fibrosus in addition to standardized conservative treatment, or (2) a control group receiving standardized conservative treatment alone. The conservative treatment includes patient education, nerve gliding exercises, tendon gliding exercises, stretching, and activity modification. The intervention period is 4 weeks.

Outcomes: The primary outcomes are feasibility measures including recruitment rate, retention rate, and adherence to the Kinesio Taping protocol. Secondary outcomes include pain intensity measured by the Numeric Pain Rating Scale, upper extremity function measured by the Quick Disabilities of the Arm, Shoulder and Hand questionnaire, grip strength measured by a hydraulic hand dynamometer, and tip, key, and palmar pinch strength measured by a calibrated pinch gauge. All secondary outcomes are assessed at baseline and at 4 weeks.

Significance: This pilot study will provide essential data on the feasibility of conducting a Kinesio Taping intervention trial in the West Bank, Palestine, and will generate preliminary estimates of treatment effects to inform the design of a future definitive randomized controlled trial.

연구 개요

상태

완전한

정황

개입 / 치료

상세 설명

Background and Rationale

Lacertus syndrome is a dynamic compression of the median nerve at the lacertus fibrosus (bicipital aponeurosis) in the proximal forearm. It is often underdiagnosed and frequently misdiagnosed as carpal tunnel syndrome. Surgical release is the current standard of care, but surgery may not be accessible, feasible, or preferred by all patients, particularly in resource-constrained health systems, and no high-quality randomized controlled trials have evaluated non-surgical treatment for this condition. Systematic reviews and meta-analyses have shown that Kinesio Taping can reduce pain and improve function in carpal tunnel syndrome, another median nerve entrapment neuropathy, which provides a rationale for testing it in lacertus syndrome. The study is guided by the International Classification of Functioning, Disability and Health (Brief ICF Core Set for Hand Conditions), with Kinesio Taping viewed as a facilitator within the environmental factors domain.

Study Design

This is a pilot, single-blind, parallel-group randomized controlled trial with a 1:1 allocation ratio, designed following SPIRIT 2013 guidelines and reported according to the CONSORT extension for pilot and feasibility trials. The target sample of 30 participants (15 per group) follows established guidance for pilot and feasibility studies, which recommends samples of approximately 24 to 50 participants in order to estimate the standard deviation of candidate outcome measures with reasonable precision for planning a future definitive trial. The study will not be powered to detect statistically significant differences between groups; its purpose is to establish feasibility and to generate preliminary parameter estimates.

Setting and Recruitment

Participants will be recruited at two outpatient centers in the West Bank, Palestine, one in Ramallah and one in Nablus, where the collaborating hand surgeon practices. During routine clinical care, the hand surgeon will identify patients with suspected lacertus syndrome, establish the diagnosis, and confirm eligibility. He will then refer interested patients to the principal investigator, who will explain the study and obtain written informed consent in Arabic before the baseline assessment.

Allocation

After consent and the baseline assessment, participants will be allocated by covariate-adaptive minimization (Pocock and Simon method). The algorithm will balance age (40 years or younger versus older than 40), gender, symptom duration (4 to 12 weeks versus more than 12 weeks), baseline pain intensity (Numeric Pain Rating Scale score of 5 or less versus greater than 5), and recruitment site. A biased coin probability of 0.75 will favor the allocation that minimizes imbalance. Allocation will be carried out by the hand surgeon's clinic secretary, an administrative staff member with no role in diagnosis, treatment, or outcome assessment, using a spreadsheet that applies the minimization method. The secretary will tell the allocation only to the treating clinician at the participant's site.

Treating Clinicians

At each site, one treating clinician (an occupational therapist or physiotherapist with at least 3 years of musculoskeletal experience) will deliver all treatment described under Arms and Interventions, after a 90-minute orientation on the study protocols given by the principal investigator before recruitment begins.

Outcome Assessment and Blinding

Outcomes will be assessed at baseline, following enrollment and prior to group allocation, and at the end of the 4-week intervention period. The outcome assessor will be the principal investigator, who will have no role in diagnosis, allocation, or treatment. At each assessment, the assessor will first measure grip and pinch strength. Participants will then complete the pain and QuickDASH questionnaires on their own using an electronic form, without the assessor seeing their answers. The clinic secretary will keep the allocation list, the questionnaire data, and the adherence logs until all week-4 assessments are finished. Participants in the taping group will remove the tape 72 hours before the week-4 assessment and clean the skin, and all participants will be asked not to discuss their treatment with the assessor. Weekly follow-up calls and any contact about side effects will be handled by the treating clinicians, not by the assessor.

Data Analysis

Descriptive statistics will summarize feasibility outcomes and baseline characteristics. For secondary effectiveness outcomes, analysis will follow the intention-to-treat principle. Change scores from baseline to 4 weeks will be compared between groups using independent t-tests or Mann-Whitney U tests depending on data distribution (assessed by the Shapiro-Wilk test). Effect sizes (Cohen's d) with 95% confidence intervals will be calculated. A significance level of 0.05 will be used. Multiple imputation with 20 imputed datasets will handle missing data, with sensitivity analyses including complete case analysis, per-protocol analysis, and pattern mixture models.

Safety Monitoring

All participants will undergo skin patch testing prior to the first tape application. Adverse skin reactions will be classified using a standardized four-grade scale and managed per a predefined protocol. Participants will record skin reactions and other adverse events in a daily log, and the treating clinicians will ask about them during the weekly telephone calls. All adverse events will be documented and reported to the Institutional Review Board according to Good Clinical Practice guidelines.

Ethical Considerations

This study will be conducted in accordance with the Declaration of Helsinki and has been approved by the Institutional Review Board of the Arab American University of Palestine - Ramallah (approval number R-2026/A/15/N, approved February 3, 2026). All participants will provide written informed consent in Arabic prior to enrollment. All data will be anonymized to preserve participant confidentiality.

Changes to the Protocol (note added November 2026)

Before recruitment opened on April 1, 2026, some procedures were changed, mainly because the study had no funding for research staff or a web-based randomization system. The changes were reported to the Institutional Review Board before recruitment, but this description was only updated in November 2026, after the trial had ended. The original version stated that treating clinicians would refer patients and the principal investigator would screen them for eligibility; that an independent statistician would hold the allocation sequence in a password-protected web-based system; that participants would wear long sleeves during assessments; and that research staff would carry out weekly clinical assessments. The procedures actually used are described above. The protocol had also planned a research assistant as the outcome assessor; the principal investigator took this role instead. Because the masked investigator and the masked outcome assessor were the same person, masking was changed from "Double (Investigator, Outcomes Assessor)" to "Single (Outcomes Assessor)".

연구 유형

중재적

등록 (실제)

30

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Nablus, 팔레스타인 영토
        • Al-Hakim Center
      • Ramallah, 팔레스타인 영토
        • Elite for special orthopedic surgery

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Adults aged 18 to 65 years
  • Confirmed clinical diagnosis of lacertus syndrome established by a physician specializing in orthopedics, physical medicine, or neurology following a standardized multi-modal diagnostic protocol
  • Positive Hagert's triad, defined as the presence of all three of the following: (1) localized tenderness upon palpation of the lacertus fibrosus, (2) reproduction of symptoms during resisted forearm pronation, and (3) reproduction of symptoms during resisted elbow flexion
  • Positive Orthogonal Kinesiotaping Test (OKT) conducted by a trained examiner
  • Neurological evaluation excluding other median nerve entrapment syndromes such as carpal tunnel syndrome
  • Electrodiagnostic studies (electromyography and nerve conduction studies) confirming median nerve involvement and ruling out alternative sources of neural compromise including cervical radiculopathy
  • Symptom duration of at least 4 weeks to ensure subacute to chronic presentation
  • Willing and able to provide written informed consent
  • Able to attend all scheduled study visits and follow the home treatment protocol

Exclusion Criteria:

  • Previous surgery for lacertus syndrome or any other median nerve entrapment condition in the affected arm
  • Known allergy to Kinesio tape or adhesive materials
  • Dermatological condition at the intended site of tape application (e.g., open wounds, active skin infection, eczema, psoriasis)
  • Neurological disorder that could confound the assessment of lacertus syndrome symptoms (e.g., multiple sclerosis, diabetic peripheral neuropathy, cervical radiculopathy)
  • Musculoskeletal disorder in the affected upper extremity that could confound symptom assessment (e.g., lateral or medial epicondylitis, shoulder impingement, rheumatoid arthritis affecting the hand or wrist)
  • Current pregnancy
  • Receipt of corticosteroid injection for lacertus syndrome within the past 3 months
  • Current use of other therapeutic taping on the affected arm
  • Cognitive impairment that would prevent understanding of study procedures or self-application of Kinesio tape

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Kinesio Taping Plus Conservative Treatment

Participants in this arm will receive therapeutic Kinesio Taping applied with 25 to 50 percent stretch over the lacertus fibrosus region, using 5-centimeter-width elastic therapeutic tape following standardized anatomical landmarks (biceps tendon/lacertus fibrosus region, proximal pronator teres, and medial forearm fascia), reapplied every 2 to 3 days for 4 weeks. In addition, participants will receive the identical standardized conservative treatment protocol delivered to the comparator arm, including patient education, median nerve gliding exercises, tendon gliding exercises, forearm stretching exercises, activity modification guidelines, and weekly telephone follow-up

Therapeutic elastic Kinesio Tape (5 cm width) applied with 25 to 50 percent stretch over the lacertus fibrosus in the proximal forearm. The tape is applied following standardized anatomical landmarks: anchor placed without stretch over the medial epicondyle region, therapeutic zone applied with stretch directly over the lacertus fibrosus, and terminal anchor placed without stretch over the proximal forearm. The initial application is performed by a trained therapist in the clinic. Participants are trained for home reapplication through hands-on demonstration, printed step-by-step instructions, and an instructional video. Tape is reapplied every 2 to 3 days for a total of 4 weeks. Adherence is monitored using tape application logs.

A 4-week standardized conservative treatment protocol consisting of four components: (1) Education: a 30-minute session covering lacertus syndrome anatomy and pathophysiology, activity modification guidelines, and ergonomic principles, with written materials provided in Arabic; (2) Exercise program: median nerve gliding exercises (3 sets of 10 repetitions, twice daily), tendon gliding exercises for flexor tendons (3 sets of 10 repetitions, twice daily), and forearm muscle stretching (30-second holds, 3 repetitions, twice daily), with access to an instructional video; (3) Activity modification: avoidance of repetitive pronation for more than 30 minutes continuously, regular breaks every 30 minutes during repetitive activities, use of ergonomic tools, and specific workplace modifications; (4) Follow-up: standardized weekly telephone check-ins to monitor compliance and address questions, with exercise logs for tracking adherence.

활성 비교기: Conservative Treatment Alone

Participants in this arm will receive the standardized conservative treatment protocol alone, consisting of a 30-minute educational session about lacertus syndrome, a structured home exercise program (median nerve gliding exercises, tendon gliding exercises, and forearm muscle stretching performed twice daily), activity modification guidelines, and weekly telephone follow-up. All study materials will be provided in Arabic.

A 4-week standardized conservative treatment protocol consisting of four components: (1) Education: a 30-minute session covering lacertus syndrome anatomy and pathophysiology, activity modification guidelines, and ergonomic principles, with written materials provided in Arabic; (2) Exercise program: median nerve gliding exercises (3 sets of 10 repetitions, twice daily), tendon gliding exercises for flexor tendons (3 sets of 10 repetitions, twice daily), and forearm muscle stretching (30-second holds, 3 repetitions, twice daily), with access to an instructional video; (3) Activity modification: avoidance of repetitive pronation for more than 30 minutes continuously, regular breaks every 30 minutes during repetitive activities, use of ergonomic tools, and specific workplace modifications; (4) Follow-up: standardized weekly telephone check-ins to monitor compliance and address questions, with exercise logs for tracking adherence.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Retention Rate
기간: 4 weeks after baseline

The proportion of randomized participants who complete the full 4-week intervention period and the final outcome assessment. Calculated as the number of participants completing the study divided by the total number of randomized participants, expressed as a percentage.

4 weeks after baseline
Recruitment Rate
기간: Through study completion, approximately 6 months

The number of eligible participants successfully enrolled into the study per month during the 6-month recruitment period. This will be calculated as the total number of randomized participants divided by the number of months of active recruitment.

Through study completion, approximately 6 months
Adherence Rate to Kinesio Taping Protocol
기간: 4 weeks after baseline

The proportion of prescribed Kinesio Tape applications that were completed by participants in the experimental group, as documented in standardized tape application logs. Calculated as the number of actual tape applications divided by the number of expected applications over the 4-week intervention period, expressed as a percentage.

4 weeks after baseline

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Pain Intensity (Numeric Pain Rating Scale)
기간: Baseline and 4 weeks

Change in pain intensity from baseline to 4 weeks measured using the Numeric Pain Rating Scale (NRS). The NRS is an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). A negative change score indicates improvement (pain reduction). The minimal clinically important difference is 2 points.

Baseline and 4 weeks
Change in Upper Extremity Function (QuickDASH)
기간: Baseline and 4 weeks

Change in upper extremity function from baseline to 4 weeks measured using the Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH), Arabic validated version. The QuickDASH is an 11-item questionnaire scored from 0 (no disability) to 100 (most severe disability). A negative change score indicates improvement (reduced disability). The minimal clinically important difference is 8 to 16 points.

Baseline and 4 weeks
Change in Grip Strength
기간: Baseline and 4 weeks

DescriptionChange in hand grip strength from baseline to 4 weeks measured using a calibrated hydraulic hand dynamometer following standardized protocols of the American Society of Hand Therapists. Measured in kilograms. The average of three trials with 30-second rest intervals will be recorded. A positive change score indicates improvement (increased strength)

Baseline and 4 weeks
Change in Tip Pinch Strength
기간: Baseline and 4 weeks

Change in tip pinch strength from baseline to 4 weeks measured using a calibrated pinch gauge following standardized protocols of the American Society of Hand Therapists. Measured in kilograms. The average of three trials with 30-second rest intervals will be recorded

Baseline and 4 weeks
Change in Key (Lateral) Pinch Strength
기간: Baseline and 4 weeks

Change in key (lateral) pinch strength from baseline to 4 weeks measured using a calibrated pinch gauge following standardized protocols of the American Society of Hand Therapists. Measured in kilograms. The average of three trials with 30-second rest intervals will be recorded.

Baseline and 4 weeks
Change in Palmar (Three-Jaw Chuck) Pinch Strength
기간: Baseline and 4 weeks

Change in palmar (three-jaw chuck) pinch strength from baseline to 4 weeks measured using a calibrated pinch gauge following standardized protocols of the American Society of Hand Therapists. Measured in kilograms. The average of three trials with 30-second rest intervals will be recorded.

Baseline and 4 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 4월 1일

기본 완료 (실제)

2026년 7월 18일

연구 완료 (실제)

2026년 7월 18일

연구 등록 날짜

최초 제출

2026년 2월 3일

QC 기준을 충족하는 최초 제출

2026년 2월 9일

처음 게시됨 (실제)

2026년 2월 12일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 13일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 10일

마지막으로 확인됨

2026년 10월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • R-2026/A/15/N

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Individual participant data that underlie the results reported in the published article will be shared, after de-identification. This includes demographic characteristics, baseline and post-intervention scores for all outcome measures (Numeric Pain Rating Scale, QuickDASH, grip strength, and pinch strength), group allocation, and adherence data.

IPD 공유 기간

Beginning 3 months after publication of the main study results and available for 5 years following publication.

IPD 공유 액세스 기준

Researchers who provide a methodologically sound proposal for use of the data. Proposals should be directed to the principal investigator (Husam Omar Taha) at the Arab American University of Palestine. Requestors will be required to sign a data access agreement.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액
  • ICF
  • CSR

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .